scholarly journals Comparison of Two Assessment Tools that Measure Insomnia: The Insomnia Severity Index and Polysomnography

2014 ◽  
Author(s):  
KS Haghighi ◽  
Z Yazdi ◽  
M Firoozeh
Keyword(s):  
Severity Index ◽  
Assessment Tools ◽  
Insomnia Severity Index ◽  
Insomnia Severity

scholarly journals Sleep Disturbances in Individuals Quarantined Due to SARS-CoV-2 Pandemic in Poland: A Mixed Methods Design Study

2021 ◽  
Vol 10 ◽  
pp. 216495612110207
Author(s):  
Sabina Krupa ◽  
Witt Paweł ◽  
Wioletta Mędrzycka-Dąbrowska ◽  
Agnieszka Lintowska ◽  
Dorota Ozga
Keyword(s):  
Mixed Methods ◽  
Sleep Disturbances ◽  
Acute Stress ◽  
Sleep Problems ◽  
Severity Index ◽  
Structured Interview ◽  
Mixed Methods Design ◽  
Design Study ◽  
Insomnia Severity Index ◽  
Insomnia Severity

Objectives The study aimed to assess sleep disturbances in patients subjected to home quarantine due to suspected SARS-CoV-2 infection. The study used a mixed methods design study as a research methodology. Methods A semi-structured interview and the scale for Insomnia Severity Index (ISI) were used to achieve the aim of the study. The survey was conducted from 16 to 20 April 2020 and 1 to 2 September 2020 in Poland, at the during of SARS-CoV-2 epidemic in this country. The data were coded and cross-processed. The (COREQ) checklist was followed. Results Interviews with patients and a thorough analysis of recordings revealed commonly used phrases in the following categories: “anxiety”, “ Am I going crazy?”, “Sleep problems”. 10 out of 11 respondents reported sleep disorders of varying severity according to the Insomnia Severity Index scale. Patients presented a fear related to the return to society and normal functioning after quarantine. Additionally, some study participants voiced concerns related to their mental health; some cases of hallucinations were reported. Conclusions Further global population studies should be conducted to analyse this phenomenon. Acute Stress Disorder should be understood as a threat to life and health of an isolated society in quarantine. Further research in this area should be promoted and the need for global guidelines for the entire population should be developed.

The Relationship Between Smartphone Use, Insomnia, Stress, and Anxiety Among University Students: A Cross-Sectional Study

2020 ◽  
pp. 105477382098316
Author(s):  
Nisreen Al Battashi ◽  
Omar Al Omari ◽  
Murad Sawalha ◽  
Safiya Al Maktoumi ◽  
Ahmed Alsuleitini ◽  
...  
Keyword(s):  
University Students ◽  
Severity Index ◽  
Depression Anxiety Stress Scale ◽  
Cross Sectional ◽  
Convenience Sample ◽  
Insomnia Severity Index ◽  
Stress Scale ◽  
Smartphone Use ◽  
The Relationship ◽  
Insomnia Severity

The rapid increase in the number of smartphone users has raised concern about the negative psychosocial and physical effects of this use. A descriptive cross-sectional design was conducted to investigate the relationship between smartphone use, anxiety and insomnia among university students. A convenience sample of 404 students from one public university completed questionnaires with items from the Smartphone Addiction Scale, the Depression Anxiety Stress Scale and the Insomnia Severity Index, with some demographic data. High smartphone addition scale score was significantly associated with higher anxiety and stress scores of the Depression Anxiety Stress scale, and higher insomnia severity index score. The findings support the importance of an intervention program to promote appropriate use of smartphones and to improve sleep and psychological symptoms such as stress and anxiety among university students.

scholarly journals Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities

2011 ◽  
Vol 9 (1) ◽  
pp. 119 ◽  
Author(s):  
Ning Yan Gu ◽  
Marc F Botteman ◽  
Xiang Ji ◽  
Christopher F Bell ◽  
John A Carter ◽  
...  
Keyword(s):  
Severity Index ◽  
Health State ◽  
Insomnia Severity Index ◽  
Health State Utilities ◽  
Insomnia Severity

Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial

2019 ◽  
Vol 33 (11) ◽  
pp. 1388-1394 ◽  
Author(s):  
Bing Cao ◽  
Caroline Park ◽  
Joshua D Rosenblat ◽  
Yan Chen ◽  
Michelle Iacobucci ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Sleep Quality ◽  
Epworth Sleepiness Scale ◽  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Severity Index ◽  
Major Depressive ◽  
Insomnia Severity Index ◽  
Insomnia Severity

Background Sleep disturbances are frequently reported in patients with major depressive disorder. We aimed to investigate the effects of vortioxetine on sleep quality and association between changes in sleep and treatment response. Methods: This study is a post-hoc analysis of a clinical trial that sought to evaluate the sensitivity to cognitive change of THINC-integrated tool in patients with major depressive disorder. In total, 92 patients (aged 18 to 65) meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for moderate or severe major depressive disorder and 54 healthy controls were included. All patients received open-label vortioxetine (10–20 mg/day, flexibly dosed) for 8 weeks. Herein, the primary outcomes of interest were changes in sleep, as measured by the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index, between weeks 0, 2, and 8. The association between changes in sleep and depressive symptom severity was secondarily assessed. Results: We observed that sleep, as indicated by scores of Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index, was significantly poorer in patients with major depressive disorder compared to healthy controls at weeks 0, 2, and 8 ( p < 0.05). Among patients with major depressive disorder, we observed significant improvements on the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Insomnia Severity Index between weeks 0 and 8 ( p < 0.05). We observed a significant association between improvements on the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Insomnia Severity Index and improvement of depressive symptoms. Conclusion: Improvement of depressive symptoms in major depressive disorder patients treated with vortioxetine was associated with significant improvements in sleep. Furthermore, improvements in sleep were predictive of antidepressant response and were linearly correlated with improvement in overall depressive symptom severity.

Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data

2019 ◽  
Vol 56 ◽  
pp. 219-223 ◽  
Author(s):  
W. Joseph Herring ◽  
Kathryn M. Connor ◽  
Ellen Snyder ◽  
Duane B. Snavely ◽  
Charles M. Morin ◽  
...  
Keyword(s):  
Severity Index ◽  
Phase 3 ◽  
Insomnia Severity Index ◽  
Insomnia Severity

scholarly journals VILNIAUS UNIVERSITETO MEDICINOS FAKULTETO STUDENTŲ NEMIGOS SIMPTOMAI

2021 ◽  
Vol 31 (3) ◽  
pp. 65-71
Author(s):  
Beatričė Balčiūnaitė ◽  
Vaiva Būgaitė ◽  
Marius Karnickas
Keyword(s):  
Severity Index ◽  
Insomnia Severity Index ◽  
Insomnia Severity

Biomedicinos mokslų studentai dažnai patiria miego sutrikimus. Tyrimo tikslas – nustatyti nemigos simptomų paplitimą tarp Vilniaus universiteto Medicinos fakulteto studentų, įvertinti jų sunkumą, taikant nemigos sunkumo indeksą ISI (angl. Insomnia Severity Index), išsiaiškinti, kokias priemones biomedicinos studentai renkasi miego sutrikimų gydymui. Tyrimo medžiaga ir metodai. 2020 m. gruodžio – 2021 m. vasario mėnesiais į internetinę apklausą iš 32 pasirenkamųjų atsakymų į klausimus atsakė 416 Vilniaus universiteto Medicinos fakulteto biomedicinos studentų. Duomenys apdoroti Excel programa ir laikyti statistiškai reikšmingais, kai p < 0,05. Rezultatai. Apklausti visų VU MF studijų programų studentai. Iš jų: medicinos ̶ 44,5%, farmacijos ̶ 12,3%, kineziterapijos ̶ 12,3%, odontologijos ̶ 8,9%, visuomenės sveikatos ̶ 8,9%, ergoterapijos ̶ 7,2%, slaugos ̶ 5%, kiti ̶ 1%). Iš 416 respondentų 352 (84,6%) moterys ir 64 (15,4%) vyrai. Kliniškai reikšmingi nemigos simptomai, įvertinti ISI, nustatyti 165 studentams iš 416 (39,7%). Vidutinio sunkumo klinikinės nemigos simptomai nustatyti 119 iš 416 (29%), sunkios ̶ 46 iš 416 studentų (11%). Tik 50 (12%) iš 416 biomedicinos studentų žinojo, kad ilgiausia galima ūmios nemigos gydymo benzodiazepinais trukmė yra 1 mėnuo. Iš 227 studentų, patyrusių nemigos simptomus, net 65 (28,6%) užmigimui palengvinti vartojo alkoholį. Iš 227 studentų, patyrusių nemigos simptomus, 152 (67%) teigė vartoję žolinius preparatus, 87 (38,3%) ̶ melatonino preparatus, 54 (23,8%) – benzodiazepinus, 28 (12,3%) ̶ antidepresantus, 20 (8,8%) ̶ Z vaistus, 8 (3,5%) ̶ kvetiapiną, o 56 (24,7%) teigė nevartoję čia nurodytų vaistinių preparatų. Net 18 iš 54 (33,3%) studentų, nemigos simptomų gydymui vartojusių benzodiazepinus, patyrė mažiausiai vieną šalutinį reiškinį, o 4 (7,4%) atitiko priklausomybės sindromo diagnostikos kriterijus. Net 11 iš 20 (55%) studentų, nemigos simptomų gydymui vartojusių Z vaistus, patyrė mažiausiai vieną šalutinį reiškinį, o 3 (15%) atitiko priklausomybės sindromo diagnostikos kriterijus. Išvados. Kliniškai reikšmingus nemigos simptomus, įvertintus ISI, patyrė 165 studentai iš 416 (39,7%). Merginų ISI įverčiai buvo statistiškai reikšmingai aukštesni, nei vaikinų (p=0,0034). Ne medicinos programų studentų ISI įverčiai buvo statistiškai reikšmingai aukštesni, nei medicinos studentų (p=0,0001). Didžiausias nemigos simptomų paplitimas nustatytas tarp kineziterapijos (55%), mažiausias ̶ tarp medicinos studentų (31%).

Sign in / Sign up

Export Citation Format

Share Document